• Our Solution
    • Physicians
    • Patients
  • About Artrya
    • Who we are
    • Leadership Team
    • Board of Directors
    • Careers
  • Investor Relations
    • Overview
    • ASX Announcements
    • Corporate Governance
    • Company Research
  • Contact Us
Request a demonstration

Cleansing Statement

Successful A$15m Placement

Proposed issue of securities – AYA

Investor Presentation

AYA Secures Multi-Year Contract with Sonic Healthcare

Trading Halt

Notification of cessation of securities – AYA

Quarterly Activities/Appendix 4C Cash Flow Report

Response to ASX Price Query

Notification regarding unquoted securities – AYA

Previous 1 2 3 Next

Precise diagnosis. Personalized treatment.
Preventative care.

Choose Artrya as your trusted clinical partner.

Contact us today
Coronary artery disease.
We see you.

Sign up to our newsletter

Request a Demo
Contact Us

About Artrya
Investor Relations

Location
1257 Hay Street, West Perth, 6005
Follow us
X
LinkedIn

Salix Coronary Anatomy is listed on the Australian Register of Therapeutic Goods, ID 347719.  Salix Coronary Anatomy USA product (K243038) is cleared in the USA. 
For the availability of Salix in the EU, UK, US or other jurisdictions, please contact us.

© 2025, Artrya. All rights reserved. Privacy Policy Terms and Conditions Indications for Use